Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: May 2013

28 - Brain imaging

from Section 5 - The promise of biomarkers and response prediction


This chapter focuses on a member of a much larger family of interventions known as cognitive behavior therapy (CBT). Cognitive therapy (CT) was first developed as a time-limited treatment of depression. Dysfunctional cognitions about medication can be modified with CT, and behavioral interventions, such as reminder systems and behavioral plans to overcome obstacles to adherence, can be used. The efficacy of CT has been subjected to hundreds of controlled investigations across a wide range of disorders. CT is the most exhaustively studied psychosocial intervention for depressive disorders. The primary analyses of six subsequent studies, all making greater efforts to ensure that pharmacotherapy was adequately administered, found CT and pharmacotherapy to be comparably effective across 12-16 weeks. It is noteworthy that the two most recent studies used selective serotonin reuptake inhibitors and, hence, have greater generalizability to contemporary practice.

Related content

Powered by UNSILO


Adler, C.M., Holland, al. (2004). Changes in neuronal activation in patients with bipolar disorder during performance of a working memory task. Bipolar Disorders, 6, 540–549.
al-Mousawi, A.H., Evans, al. (1996). Limbic dysfunction in schizophrenia and mania: A study using 18F-labelled fluorodeoxyglucose and positron emission tomography. British Journal of Psychiatry, 169, 509–516.
Altshuler, L., Bookheimer, al. (2005). Increased amygdala activation during mania: a functional magnetic resonance imaging study. American Journal of Psychiatry, 162, 1211–1213.
Arnone, D., Cavanagh, al. (2009). Magnetic resonance imaging studies in bipolar disorder and schizophrenia: Meta-analysis. British Journal of Psychiatry, 195, 194–201.
Beyer, J.L., Young, al. (2009). Hyperintense MRI lesions in bipolar disorder: a meta-analysis and review. Int Rev Psychiatry, 21, 394–409.
Blumberg, H.P., Stern, al. (1999). Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. American Journal of Psychiatry, 156, 1986–1988.
Blumberg, H.P., Stern, al. (2000). Increased anterior cingulate and caudate activity in bipolar mania. Biological Psychiatry, 48, 1045–1052.
Brockmann, H., Zobel, al. (2009). The value of HMPAO SPECT in predicting treatment response to citalopram in patients with major depression. Psychiatry Research, 173, 107–112.
Brunswick, D.J., Amsterdam, al. (2003). Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging. American Journal of Psychiatry, 160, 1836–1841.
Cannon, D.M., Ichise, al. (2006). Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry, 60, 207–217.
Cannon, D.M., Klaver, al. (2009). Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112. Neuropsychopharmacology, 34, 1277–1287.
Chen, C.H., Lennox, al. (2006). Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: a functional magnetic resonance imaging study. Biological Psychiatry, 59, 31–39.
Cole, J., Costafreda, al. (2011). Hippocampal atrophy in first episode depression: A meta-analysis of magnetic resonance imaging studies. Journal of Affective Disorders, 134, 483–487.
D’Haenen, H.A. and Bossuyt, A. (1994). Dopamine D2 receptors in depression measured with single photon emission computed tomography. Biological Psychiatry, 35, 128–132.
Drevets, W.C., Savitz, al. (2008). The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums, 13, 663–681.
Emsell, L. and McDonald, C. (2009). The structural neuroimaging of bipolar disorder. International Review of Psychiatry, 21, 297–313.
Fitzgerald, P.B., Oxley, al. (2006). An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression. Psychiatry Research, 148, 33–45.
Fitzgerald, P.B., Laird, al. (2008). A meta-analytic study of changes in brain activation in depression. Human Brain Mapping, 29, 683–695.
Frodl, T., Meisenzahl, al. (2004). Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. Journal of Clinical Psychiatry, 65, 492–499.
Gonul, A.S., Coburn, al. (2009). Cerebral blood flow, metabolic, receptor, and transporter changes in bipolar disorder: The role of PET and SPECT studies. International Review of Psychiatry, 21, 323–335.
Gruber, S.A., Rogowska, al. (2004). Decreased activation of the anterior cingulate in bipolar patients: An fMRI study. Journal of Affective Disorders, 82, 191–201.
Hamilton, J.P., Siemer, al. (2008). Amygdala volume in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Molecular Psychiatry, 13, 993–1000.
Hasler, G. and Northoff, G. (2011). Discovering imaging endophenotypes for major depression. Molecular Psychiatry, 16, 604–619.
Heng, S., Song, al. (2010). White matter abnormalities in bipolar disorder: Insights from diffusion tensor imaging studies. Journal of Neural Transmission, 117, 639–654.
Hirvonen, J., Karlsson, al. (2008). Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET. Psychopharmacology (Berl), 197, 581–590.
Hsieh, M.H., McQuoid, al. (2002). Hippocampal volume and antidepressant response in geriatric depression. International Journal of Geriatric Psychiatry, 17, 519–525.
Ichimiya, T., Suhara, al. (2002). Serotonin transporter binding in patients with mood disorders: A PET study with [11C](+)McN5652. Biological Psychiatry, 51, 715–722.
Kempton, M.J., Geddes, al. (2008). Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Archives of General Psychiatry, 65, 1017–1032.
Kempton, M.J., Salvador, al. (2011). Structural neuroimaging studies in major depressive disorder: Meta-analysis and comparison with bipolar disorder. Archives of General Psychiatry, 68, 675–690.
Koolschijn, P.C., van Haren, al. (2009). Brain volume abnormalities in major depressive disorder: A meta-analysis of magnetic resonance imaging studies. Human Brain Mapping, 30, 3719–3735.
Kronhaus, D.M., Lawrence, al. (2006). Stroop performance in bipolar disorder: Further evidence for abnormalities in the ventral prefrontal cortex. Bipolar Disorders, 8, 28–39.
Kronmuller, K.T., Pantel, al. (2008). Hippocampal volume and 2-year outcome in depression. British Journal of Psychiatry, 192, 472–473.
Kuhn, S. and Gallinat, J. (2011). Resting-state brain activity in schizophrenia and major depression: a quantitative meta-analysis. Schizophrenia Bulletin.
MacQueen, G.M., Yucel, al. (2008). Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biological Psychiatry, 64, 880–883.
Mahon, K., Burdick, al. (2010). A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neuroscience Biobehavioral Reviews, 34, 533–554.
Malhi, G.S., Lagopoulos, al. (2005). An emotional Stroop functional MRI study of euthymic bipolar disorder. Bipolar Disorders, 7, 58–69.
Malhi, G.S., Lagopoulos, al. (2004). Cognitive generation of affect in bipolar depression: An fMRI study. Europen Journal of Neuroscience, 19, 741–754.
Mayberg, H.S., Brannan, al. (2000). Regional metabolic effects of fluoxetine in major depression: Serial changes and relationship to clinical response. Biological Psychiatry, 48, 830–843.
Meyer, J.H., Kapur, al. (1999). Prefrontal cortex 5-HT2 receptors in depression: An [18F]setoperone PET imaging study. American Journal of Psychiatry, 156, 1029–1034.
Meyer, J.H., Kruger, al. (2001). Lower dopamine transporter binding potential in striatum during depression. NeuroReport, 12, 4121–4125.
Meyer, J.H., Houle, al. (2004). Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Archives of General Psychiatry, 61, 1271–1279.
Meyer, J.H., Ginovart, al. (2006). Elevated monoamine oxidase a levels in the brain: An explanation for the monoamine imbalance of major depression. Archives of General Psychiatry, 63, 1209–1216.
Meyer, J.H., Wilson, al. (2009). Brain monoamine oxidase A binding in major depressive disorder: Relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Archives of General Psychiatry, 66, 1304–1312.
Milak, M.S., Parsey, al. (2009). Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Research, 173, 63–70.
Miller, J.M., Oquendo, al. (2008). Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder. Journal Psychiatric Research, 42, 1137–1144.
Montgomery, A.J., Stokes, al. (2007). Extrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 and [11C]raclopride. Journal of Affective Disorders, 101, 113–122.
Oquendo, M.A., Hastings, al. (2007). Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography. Archives of General Psychiatry, 64, 201–208.
Pan, L., Keener, al. (2009). Functional neuroimaging studies of bipolar disorder: Examining the wide clinical spectrum in the search for disease endophenotypes. International Review of Psychiatry, 21, 368–379.
Parsey, R.V. (2010). Serotonin receptor imaging: clinically useful? Journal of Nuclear Medicine, 51, 1495–1498.
Parsey, R.V., Oquendo, al. (2001). Dopamine D(2) receptor availability and amphetamine-induced dopamine release in unipolar depression. Biological Psychiatry, 50, 313–322.
Parsey, R.V., Oquendo, al. (2006a). Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study. Biological Psychiatry, 59, 106–113.
Parsey, R.V., Hastings, al. (2006a). Lower serotonin transporter binding potential in the human brain during major depressive episodes. American Journal of Psychiatry, 163, 52–58.
Sargent, P.A., Rabiner, al. (2010). 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl- (11)C]WAY-100635. Journal of Affective Disorders, 123, 77–80.
Savitz, J.B. and Drevets, W.C. (2009). Imaging phenotypes of major depressive disorder: Genetic correlates. Neuroscience, 164, 300–330.
Sax, K.W., Strakowski, al. (1999). Frontosubcortical neuroanatomy and the continuous performance test in mania. American Journal of Psychiatry, 156, 139–141.
Sheline, Y.I. (2003). Neuroimaging studies of mood disorder effects on the brain. Biological Psychiatry, 54, 338–352.
Sheline, Y.I., Barch, al. (2001). Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biological Psychiatry, 50 651–658.
Soares, J.C. and Mann, J.J. (1997). The anatomy of mood disorders–review of structural neuroimaging studies. Biological Psychiatry, 41, 86–106.
Strakowski, S.M., Adler, al. (2005a). Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task. American Journal of Psychiatry, 162, 1697–1705.
Strakowski, S.M., DelBello, al. (2005b). The functional neuroanatomy of bipolar disorder: A review of neuroimaging findings. Molecular Psychiatry, 10, 105–116.
Sullivan, G.M., Ogden, al. (2009). Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biological Psychiatry, 66, 223–230.
Vakili, K., Pillay, al. (2000). Hippocampal volume in primary unipolar major depression: A magnetic resonance imaging study. Biological Psychiatry, 47, 1087–1090.
Videbech, P. and Ravnkilde, B. (2004). Hippocampal volume and depression: A meta-analysis of MRI studies. American Journal of Psychiatry, 161, 1957–1966.
Warner-Schmidt, J.L. and Duman, R.S. (2006). Hippocampal neurogenesis: Opposing effects of stress and antidepressant treatment. Hippocampus, 16, 239–249.
Wessa, M., Houenou, al. (2007). Fronto-striatal overactivation in euthymic bipolar patients during an emotional go/nogo task. American Journal of Psychiatry, 164, 638–646.
Yildiz, A., Sachs, al. (2001). 31P Nuclear magnetic resonance spectroscopy findings in bipolar illness: A meta-analysis. Psychiatry Research, 106, 181–191.
Yildiz-Yesiloglu, A. and Ankerst, D.P. (2006). Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Progress in Neuropsychopharmacology and Biological Psychiatry, 30, 969–995.
Yuksel, C. and Ongur, D. (2010). Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders. Biological Psychiatry, 68, 785–794.